## Mechanistic Overview
LRRK2 Volume Sensor Hijacking Drives Metabolic Dysregulation via SIRT1/PGC1α Suppression starts from the claim that modulating not yet specified within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview LRRK2 Volume Sensor Hijacking Drives Metabolic Dysregulation via SIRT1/PGC1α Suppression starts from the claim that modulating not yet specified within the disease context of neurodegen
The most supported model is that pathogenic G2019S shifts the basal catalytic set-point upward, producing higher baseline phospho-Rab output while leaving the core lysosomal volume-sensing response architecture largely intact. In this view, mutant cells begin from a higher activity floor, and the key experimental discriminator is whether baseline-normalized EC50, slope, or Emax materially increase during graded swelling.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
1. **Title:** `G2019S raises the LRRK2 kinase floor more than the swelling gain`
**Mechanism:** G2019S may primarily increase constitutive catalytic output, producing higher baseline pRab10/pRa...
Skeptic
**Skeptical Read**
The main weakness across all six is the same: most cited evidence shows that mutant `LRRK2` can elevate phospho-Rab output or alter lysosomal remodeling, but it does **not** cleanl...
Domain Expert
As of **April 24, 2026**, the hypotheses that most credibly survive are:
1. **#1 Higher baseline kinase activity more than higher swelling gain**
2. **#4 Amplification is context-dependent and strong...
Synthesizer
{
"ranked_hypotheses": [
{
"title": "G2019S primarily raises baseline LRRK2 kinase activity rather than amplifying lysosomal swelling gain",
"description": "The most supported model ...